Two arteries supply blood to your hand. One is the radial artery, and the other is the ulnar artery. A healthy hand needs both arteries open and working. Otherwise, you could get permanent hand ...

A total of 1036 patients were included in the analysis (534 patients with radial-artery grafts and 502 patients with saphenous-vein grafts). After a mean (±SD) follow-up time of 60±30 months ...

The patient was able to go home shortly after the catheter was removed because his doctors decided to use the radial artery in his arm, rather than the femoral artery in his leg, to access his heart.

Performing angioplasty and angiography through the radial artery of the arm is as effective as the traditional method of entering through the femoral artery of the groin, but has fewer ...

Major cardiac events were fewer at 5 years in patients receiving a radial artery graft as the second conduit in coronary bypass surgery (CABG) vs a saphenous-vein graft (SVG) in a patient-level ...

With a median follow-up of 10 years after coronary artery bypass grafting (CABG), patients who received a radial artery graft rather than a saphenous vein graft as a second conduit were less ...

ROME, Italy—(UPDATED) Radial artery anomalies are present in nearly one in ten patients undergoing radial access PCI for STEMI and are a key reason for transradial failure, according to the analysis ...

The radial artery outperformed the saphenous vein, with 12 per cent of patients having a functional graft occlusion (blockage) versus 19.7 per cent of patients who received a saphenous graft.

ATLANTA -- Radial artery access for cardiac catheterization appeared similarly safe for the hand whether done proximally or distally, the randomized DIPRA trial showed. Overall change in 30-day ...

If you observe a slight bulge and a throbbing mass just beneath the skin's surface in the hand slowly increasing in size, the ...

Opens in a new tab or window BOSTON -- A short course of rivaroxaban (Xarelto) after transradial coronary procedures helped prevent radial artery occlusion complications, the RIVARAD trial from ...